Greater Cannabis Company (GCAN) Return on Assets (2018 - 2026)
Greater Cannabis Company's (GCAN) quarterly Return on Assets came in at 1.09% in Q1 2026, down 104.0% year-on-year from 27.19% in Q1 2025, and down 525.61% quarter-over-quarter from 0.17% in Q4 2025.
Greater Cannabis Company (GCAN) Return on Assets (2018 - 2026) Analysis & Trends
Greater Cannabis Company's Return on Assets history runs 9 years deep, the most recent figure standing at 1.09% for Q1 2026.
- On a quarterly basis, Return on Assets fell 104.0% year-over-year to 1.09% in Q1 2026; TTM through Mar 2026 was 1.09%, a 104.0% decrease from a year earlier, with the FY2025 full-year figure at 0.11%, down 10.0% from the prior year.
- Return on Assets slipped to 1.09% in Q1 2026 per GCAN's latest filing, from 0.17% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q3 2023 and bottomed at 1.09% in Q1 2026.
- The 5-year median for Return on Assets is 0.02% (2024), against an average of 0.11%.
- Across the five-year window, Return on Assets climbed 1 bps in 2023 and tumbled 104 bps in 2026, its largest moves.
- Year by year, Return on Assets stood at 0.01% in 2022, then grew by 20 bps to 0.01% in 2023, then tumbled by 195 bps to 0.03% in 2024, then sank by 491 bps to 0.17% in 2025, then plunged by 526 bps to 1.09% in 2026.
- Per Business Quant, the three latest GCAN Return on Assets figures stand at 1.09% (Q1 2026), 0.17% (Q4 2025), and 0.24% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00% |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | -1.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.09% |
| Dec 31, 2025 | -0.17% |
| Sep 30, 2025 | -0.24% |
| Jun 30, 2025 | -0.16% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.02% |